ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Strengthening Global Pandemic Preparedness: The Urgent Need for Investment, Collaboration, and Action

TAMPA, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- The Global Virus Network (GVN) is highly concerned that the world is unprepared for the next pandemic and has not incorporated the lessons learned from COVID-19. The GVN, comprised of 80+ Virology Centers of Excellence and Affiliates in 40+ countries, whose mission is to facilitate pandemic preparedness against viral pathogens and diseases that threaten public health globally, believes that systemic inadequacies and vulnerabilities persist, which threaten public health on a global scale. Furthermore, the need for governments and health organizations worldwide to invest and collaborate in developing and implementing an effective, comprehensive, and integrated pandemic response program is critical.

According to research by the World Health Organization (WHO) and the World Bank presented to the Group of Twenty (G20), or international forum of major economies, in 2022, an estimated USD $31.1 billion in annual funding is required to establish a comprehensive Pandemic Preparedness and Response (PPR) system. This falls at least USD $10.5 billion short of what is needed today to meet global preparedness requirements. To close this gap, urgent focus must be placed on strengthening systems that protect humanity from future, inevitable pandemic threats.

Past pandemics have shown that failing to invest in sustainable health infrastructure can devastate healthcare systems, economies, and societies. Moreover, the reductions in global health programs and grant funding have led to major setbacks in pandemic preparedness. Without stable and reliable funding, the world risks losing hard-won progress in disease surveillance, research, training, and emergency response capabilities.

As evidenced by the ongoing avian influenza (H5N1) outbreak, and described in GVN’s Lancet Regional Health—Americas publication, which was published Monday, mutations and genetic reassortment, where two influenza viruses combine, pose a significant risk of increased transmissibility and mortality, and the potential emergence of another global pandemic. These risks are further exacerbated by inadequate biosafety measures and the absence of a robust, coordinated global surveillance system capable of detecting and responding to such threats in real time.

To mitigate these dangers, the GVN believes immediate action is crucial to close the critical gaps in global preparedness and ensure a world ready to respond to future pandemics   GVN will continue to promote sustained investment in pandemic preparedness throughout the world, especially for research and training, to ensure scientists, public health experts, and first responders have the necessary resources to detect, prevent, and control viral threats. Strengthening partnerships with global health organizations, governments, and the scientific community remains essential in addressing cross-border health challenges.

Additionally, clear and transparent communication and efforts to deal with a lack of knowledge and understanding, counter misinformation, and address vaccine hesitancy are critical to ensuring public health, restoring public trust, and ensuring compliance with health measures. The rapid spread of misinformation during the COVID-19 pandemic, and now in measles outbreaks seen globally, highlights the necessity of reliable, science-based public health information.

About the Global Virus Network

The Global Virus Network (GVN) is a worldwide coalition comprising 80+ Virology Centers of Excellence and Affiliates across 40+ countries, whose mission is to facilitate pandemic preparedness against viral pathogens and diseases that threaten public health globally. GVN advances knowledge of viruses through (i) data-driven research and solutions, (ii) fostering the next generation of virology leaders, and (iii) enhancing global resources for readiness and response to emerging viral threats. GVN provides the essential expertise required to discover and diagnose viruses that threaten public health, understand how such viruses spread illnesses, and facilitate the development of diagnostics, therapies, and treatments to combat them. GVN coordinates and collaborates with local, national, and international scientific institutions and government agencies to provide real-time virus informatics, surveillance, and response resources and strategies. GVN's pandemic preparedness mission is achieved by focusing on Education & Training, Qualitative & Quantitative Research, and Global Health Strategies & Solutions.

The GVN is a non-profit 501(c)(3) organization. For more information, please visit www.gvn.org

Media Contact:
Nora Samaranayake, GVN
nsamaranayake@gvn.org 


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.